Skip to main content

Current Funding Announcements

See below

fy20 jwmrp advancement of previous department of defense (dod) or service funded medical research and development (R&D) projects

W81XWH-20-RFI-JWMRP: FY20 JWMRP Advancement of Previous Department of Defense (DoD) or Service 

Funded Medical Research and Development (R&D) Projects
Description: This is an RFI released by the Joint Warfighter Medical Research Program (JWMRP), managed by the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC). JWMRP provides an opportunity to advance previously funded DoD or Service medical R&D projects that address the medical requirements of the Services. Science and technology development efforts are aligned to one of the six Joint Program Committee (JPC) scientific domains, including Military Operational Medicine (JPC-5) whose focus areas include environmental health/protection and injury prevention/reduction; Combat Casualty Care (JPC-6) whose focus areas include diagnosis and reduction of TBI-related impairments; and Clinical and Rehabilitative Medicine (JPC-8) whose focus areas include sensory systems impairment (including hearing, balance, tinnitus). 

Funds appropriated for the JWMRP shall be used to augment and accelerate high priority DoD and Service medical requirements and to continue prior year initiatives that are close to achieving their objectives and yield a benefit to military medicine. These funds shall not be used for new projects or for basic research.


This RFI is issued solely for information and planning purposes. To be considered for the FY20 JWMRP, PIs must submit a Letter of Interest (LOI) due by 1200 on 20 February.


Letter of Interest due: 12:00 PM Eastern, 20 February 2020


Content POC (email only): Doug Medcalf:


Engineering Next-Generation Human nervous System Microphysiological systems (clinical Trials not allowed)

Description: This Funding Opportunity Announcement (FOA) encourages research grant applications 
directed toward developing next-generation human cell-derived microphysiological systems (MPS) and 
related assays that replicate complex nervous system architectures and physiology with improved 
fidelity over current capabilities. The purpose of this FOA is to stimulate basic 
technology-focused research to develop next-generation human cell-derived microphysiological 
systems (MPS) and related assays with improved fidelity to complex human brain, spinal cord, and/or 
sensory end organ circuit physiology, which will ultimately facilitate analysis of higher order 
functional deficits relevant to complex nervous system diseases.

This FOA encourages innovative approaches that are first-in-class, those that propose to 
substantially exceed the state of the art in tissue organization and function. These can be high 
risk, high impact designs. Additionally, this FOA encourages approaches that aim to improve 
robustness and reproducibility of physiologically relevant circuit or supportive systems-level 

PAR-20-055: R01 Research Project Grant – this mechanism is intended to provide support for the 
further development of projects where preliminary data supports the feasibility of the line of 
investigation. Applicants without preliminary data may wish to apply to the companion R21 FOA.

PAR-20-082: R21 Exploratory/Developmental Research Grant – this grant mechanism is intended to 
encourage exploratory/developmental research by providing support for the early and conceptual 
stages of project development. High risk/high reward projects that lack preliminary data may be 
most appropriate for this FOA. Applicants with preliminary data may wish to apply to the companion 
R01 mechanism.

NIH Institutes and Centers participating in this FOA have specific interests and priorities, 

National Institute on Deafness and Other Communication Disorders (NIDCD)
• The institute is interested in a broad variety of approaches and technology/methodology 
development. Some examples, but not limited to, would be technical development of microarchitecture 
reagents including appropriate buffers, media, polymers and synthetics to generate improved 3D 
platforms and microenvironments to facilitate cellular attachment, proliferation, in areas of 
differentiation or regeneration of taste buds, hearing/balance sensory epithelium, or vocal folds; 
experimental improvements of drug assessment studies, high throughput replication and comparative 
analyses of laryngeal, chemosensory and auditory/vestibular function (e.g., ototoxicity, noise or 
drug trauma, and age-related sensory loss); experimental improvements to implantable chip or scaffold-derived


mtec navy multi-topic: advanced biomedical product development for naval operations


MTEC Navy Multi-Topic: Advanced Biomedical Product Development for Naval Operations

MTEC-20-02-NavyMulti (release anticipated early January 2020) MTEC-20-03-NavyMulti (release anticipated early March 2020)

Description: This is a pre-announcement for multiple RFPs (two white paper submissions anticipated) focused on the advancement of engineering and medical prototypes and knowledge products relevant to enhanced readiness and resilience of Navy and Marine Corps health and performance. To maintain warfighter lethality and operational effectiveness in challenging environments, next generation biomedical products are required. Projects shall not be exploratory, and do require a foundation of preliminary data. MTEC-sponsored projects must result in “prototype” research deliverables that transition medical solutions to industry. Proposed prototypes shall be at a minimum of a TRL of 5 at the time of submission and address at least one Technology Focus Area, which include:

•    Casualty care (MTEC-20-02-NavyMulti)
•    Medical logistics enhancement (MTEC-20-02-NavyMulti)
•    Human performance ((MTEC-20-02-NavyMulti, MTEC-20-03-NavyMulti)
•    Prolonged and en route care (MTEC-20-03-NavyMulti)
•    Operational readiness (MTEC-20-03-NavyMulti)

Anticipated White Paper Due Dates: early February 2020 (MTEC-20-02-NavyMulti) and late April 2020 
Periods of performance: 12-36 months
Awards: $500,000 - $2M

For more information:


Hearing health foundation (HHF)'s 2020 Emerging Research grants (ERG)

Hearing Health Foundation (HHF)'s 2020 Emerging Research Grants (ERG)

DESCRIPTION: HHF's ERG grants provide seed money to stimulate data collection that leads to a continuing, independently fundable line of research. ERG Grantees advance scientific knowledge in the following under-researched areas: Hearing Loss in Children, Central Auditory Processing Disorder, Hyperacusis, Tinnitus, Ménière’s disease, Usher syndrome, making cancer drugs less ototoxic, and the links between hearing loss and diabetes, heart and kidney disease.

APPLICATIONS OPEN October 14, 2019


FUNDING Up to $50,000 per year for each project for an initial period of one year, renewable for one additional year. PROGRAM DATE October 1, 2020 – September 30, 2021


Questions about grant program and processes:

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (r01 basic experimental studies with humans required

PAR-19-384: Research on biopsychosocial factors of social connectedness and isolation on health, 
wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required
Description: This funding opportunity announcement (FOA) invites research projects that seek to 
explain the underlying mechanisms, processes, and trajectories of social relationships and how 
these factors affect outcomes in human health, illness, recovery, and overall wellbeing.
Types of projects submitted under this FOA include studies that prospectively assign human 
participants to conditions (i.e., experimentally manipulate independent variables) and that assess 
biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena 
related to social connectedness and isolatedness.

Applications submitted cannot include any specific aims that propose to measure clinical efficacy 
or effectiveness of any intervention. Investigators who wish to conduct studies with clinical 
endpoints as the primary outcomes should consider other NIH FOAs.

NIH Institutes and Centers participating in this FOA have specific interests and priorities, 

National Institute on Deafness and Other Communication Disorders (NIDCD)
• Social connection and isolation across the lifespan in people with communication disorders
• NIDCD will accept applications when/if including human participants living with disorders of 
hearing, balance/vestibular, voice, speech, language, taste and smell.
•    Contact: Lana Shekim, PhD
National Institute on Deafness and Communication Disorders (NIDCD) Telephone: 301-496-5061
Open Date (Earliest Submission Date): February 17, 2020
Application Due Date(s): March 17, 2020; March 17, 2021
Expiration Date: March 18, 2021

Maximum Project Period: 5 years
Amount: must reflect actual needs of the proposed project
Additional Information:

American Otological Society Research Foundation

If you would like to submit a grant for consideration of funding in 2020-2021, a LETTER OF INTENT and BIOSKETCH, including details regarding other existing support, must be submitted by November 1st of the year prior to funding. The next funding cycle begins July 1, 2020. The letter of intent must state the desired grant mechanism for the proposal (CSA, Fellowship grant, Research Grant), the Principal Investigator and Institution(s), a working title and abstract and include Specific Aims and a proposal summary (2 page limit on abstract and aims).

Find more information at:  

Combat Readiness-Medical research program rapid development and translational research award

W81XWH-19-S-CRRP Combat Readiness – Medical Research Program Rapid

Development and Translational Research Award


Description: The CRRP was initiated by Congress in FY19 to pursue military-relevant advanced technology and therapeutic research related to forward deployable solutions that can promptly address life-threatening injuries, medical threats, and treatments for Warfighters in current and future battlefield settings. The Congressional language for the CRRP encompasses research that would enable the Warfighter to better respond to serious injury, as well as solutions to mitigate the long-term effects of battlefield trauma, including: (1) enhancing battlefield diagnostics for neurological injuries and hemorrhage; DoD FY19 CRRP Rapid Development and Translational Research Award 4 (2) integrated wound care and tissue regeneration therapies; (3) environmental and wearable sensors, combined with advanced computing, for surveillance and monitoring of chemical and biological threat exposures; (4) telemedicine applications for battlefield medicine, to allow for better collection, integration, and transfer of patient data from battlefield medical units through transport and treatment; (5) chemical and biological exposure, countermeasures, and management strategies; and (6) solutions for infectious disease management, including sepsis. The CRRP vision is to deliver high-impact medical solutions throughout the continuum of care to increase survivability and readiness of the Warfighter in diverse operational settings. Per the program’s mission statement, the CRRP seeks to develop innovative solutions to increase medical readiness, mitigate fatalities, optimally treat life-threatening injuries, and promote positive long-term outcomes. Innovations developed by CRRP-supported research may be applied proactively as a way to establish medical readiness ahead of deployment, in-theater at the point of injury or during periods of prolonged care, or during transport/en route care within and from theater. These solutions will not only help to minimize the morbidity and mortality of combat-related injuries sustained by the Warfighter, they will also often translate to civilian care.

Focus areas include wearable sensors with multiple capabilities to identify and monitor medical management of injuries and/or exposures, such as environmental exposures and neurological injury.

Pre-app due: 23 October 2019

Full app due: 13 November 2019 Period of Performance: 2 years Max Funding: $1.5M

For more information,


Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required)

RFA-HL-20-030: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required)

Description: The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seek highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells.


Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials. This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan.


Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans.


Due to the complex nature of requirements in this FOA (e.g., 1:1 matching funds, resource sharing), applicants are strongly encouraged to communicate with the appropriate NIH Scientific/Research Contact and review online Frequently Asked Questions (FAQs) prior to submitting an application. Staff will be able to advise applicants in determining if their research meets the requirements and objectives of this FOA.


Scientific/research contact for NIDCD:


  • Nancy L. Freeman, Ph.D.

National Institute on Deafness and Other Communication Disorders (NIDCD) Telephone: 301-402-3458


Letter of Intent: September 18, 2019

Application: October 18, 2019

Maximum total project period: 5 years


Dod complex traumatic brain injury rehabilitation research - clinical research award


DoD Complex Traumatic Brain Injury Rehabilitation Research - Clinical Research Award


Description: The FY19 PH/TBIRP CTRR-CRA is intended to support clinical research focused on understanding the clinical sequelae and mechanisms of recovery associated with mTBI and TBI- related cognitive, sensory, and motor performances. The overarching goals of this award are to address TBI-related impairments and deficits, including multi-modal and cognitive dysfunction, to (1) develop and validate rehabilitation outcome measures; (2) systematically analyze standard of care cognitive interventions to identify optimal treatment ingredients; and (3) improve clinician-driven assessment strategies to guide RTD decision-making. The FY19 PH/TBIRP CTRR-CRA seeks research to develop and validate novel outcome measures that will characterize and track functional cognitive, sensory, and motor performance deficit in Service members and relevant populations with cognitive dysfunction following TBI; and to identify key treatment approaches to optimize cognitive rehabilitation following TBI, as consistent with the mission of the JPC-8/CRMRP.

Supported research should investigate effectiveness of rehabilitation in remediating postconcussive sequelae across the spectrum of known post-concussive vulnerabilities in the areas DoD FY19 PH/TBIRP CTRR – Clinical Research Award 4 of post-traumatic dizziness, vestibular dysfunction, imbalance or dynamic instability; visual and oculomotor dysfunction; cognitive deficits (e.g., degraded processing speed, memory, or executive functioning); central auditory processing; and autonomic dysregulation. Solutions should integrate objective clinical findings in the following domains: cognitive performance, sensory function, and motor performance.


The CRA mechanism supports applied and translational clinical research to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI. Clinical trials are not supported by this mechanism. Studies involving animal research do not meet the intent of this award mechanism.

Pre-app due: 10 September 2019

Full app due: 2 December 2019 Period of Performance: 3 years Max Funding: $2M

For more information,



 W81XWH-19-DMRDP-AIMM - Accelerating Innovation in Military Medicine Research Award

Description: The AIMM initiative was created to accelerate transformational biomedical research for our Armed Forces and Nation. The mission of the AIMM initiative is to encourage, identify, and enable innovative research that leads to crosscutting solutions to military health threats. The FY19 appropriation is $3M. To meet the intent of the award mechanism, applications submitted to the FY19 AIMM must address at least one of the Focus Areas listed below. Applications that will accelerate research toward innovations applicable to multi-domain operations and multi-domain operations in dense urban environments are encouraged but not required.

The FY19 AIMM Focus Areas are as follows:

• Algorithms/tools for decision support in a deployed or operational environment to: diagnose military-relevant disease, illness, or injury; prescribe mitigation and treatment strategies; and/or determine risk of Warfighter return to duty.

• Artificial Intelligence (AI)/deep learning for integrating heterogeneous data streams and analyzing data from wearables to support making informed healthcare decisions. Wearable sensor systems may pertain to, but are not limited to, the following or combinations of the following: infectious disease diagnosis; physiologic status monitoring; informing real-time casualty location and triage; and/or environmental monitoring.

• AI/deep learning for analyzing and interrogating large medical data sets to: identify patterns/predictors of disease, illness, or injury; and/or identify treatment outcomes.


Pre-app due: 26 July 2019

Full app due: 30 October 2019

Period of Performance: 18 months

Max Funding: $350,000

For more information,

DoD Hearing Restoration Focused Program Award

W81XWH-19-HRRP-FRA – DoD Hearing Restoration Focused Program Award

Description: The HRRP was initiated in 2017 to support innovative and impactful research that pursues the treatment of auditory system injuries and the restoration of hearing. The HRRP will fund innovative research that has the potential to maximize operational performance, medical readiness, and quality of life for Service members, Veterans, and others living with significant auditory system injuries. Tinnitus or vestibular-related research is excluded. All applications to the FY19 HRRP FRA must address research in one or more of the following Focus Areas:

• Develop or validate techniques/methods to assess, diagnose, or treat auditory dysfunction as related to synaptopathy, hidden hearing loss, and central auditory processing disorders. Examples include, but are not limited to:

o Diagnostic tests that help differentiate sensory, neural, synaptic, and central processing disorders

o Diagnostic tools for use in forward or remote deployed settings to assess hidden hearing loss and to inform whether the individual’s hearing capability is sufficient to perform the duties of the job or work assignment

o Treatments for the various types of damage that result in the auditory dysfunction leading to decreased ability to adequately perform the duties of the job or work assignment

• Accelerate translation of biological regeneration/repair mechanisms into therapies that restore auditory function. Examples include, but are not limited to:

o Treatments to enhance synaptic plasticity

o Hair cell regeneration/repair/recovery

o Neural regeneration/repair/recovery

• Develop reliable in-vitro human models for evaluating hearing restoration therapies


Funding Level 1 supports exploratory, high-risk/high-reward research that is in the earliest stages of idea development.

Funding Level 2 supports the advancement of more mature research toward clinical translation.

Pre-app due: 16 July 2019

Full app due: 14 November 2019

Period of Performance: 2 years (Level 1), 3 years (Level 2)

Max Funding: The anticipated direct costs budgeted for the entire period of performance for an FY19 HRRP FRA Funding Level 1 will not exceed $250,000. The anticipated direct costs budgeted for the entire period of performance for an FY19 HRRP FRA Funding Level 2 will not exceed $1,000,000 or $1,250,000 for applications with a pilot clinical trial option.

For more information,

Army Research Office Broad Agency Announcement for Fundamental Research

Announcement: Funding


Type/Mechanism: Grant
Funding Opportunity Number: 

Application Open:  1 April, 2017 – 31 March 2022

Notes:  (See below for additional info)

Description: ARO is focused exclusively on extramural basic research, and is responsible for the vast majority of ARL’s extramural research programs and funding. Competencies are structured to create discovery, innovation, and transition of technologies leading to Power Projection Superiority, Information Supremacy, Lethality and Protection Superiority, and Soldier Performance Augmentation for Strategic Land Power Dominance. Proposals are expected to be for cutting-edge innovative research that could produce discoveries that would have a significant impact on enabling new and improved Army operational capabilities and related technologies. Specific research areas and topics of interest should be viewed as suggestive, rather than limiting. ARO is always interested in considering new innovative research concepts of relevance to the Army. Additional information about ARO areas of interest can be found on the ARL website:

Research areas of interest include

·        Life Sciences (Neurophysiology of Cognition/Multisensory Synthesis)

·        Intelligent Systems for Improved Decision Making (sensing, perception, situation awareness)

·        Biomathematics (modeling sensory processing, disease processes)

·        International Opportunities: Human Dimension, Big Data

This Funding Opportunity Announcement is a BAA. It is continuously open for a 5-year period, from 01 April 2017 closing 31 March 2022. Proposals will be considered until and including the closing date of this announcement.

There are no specific funding restrictions associated with this BAA. The proposed duration for which support is requested should be consistent with the nature and complexity of the proposed activity.

For more information,

NIDCD Clinical Research Center Grant (P50/Clinical Trial Optional)

Announcement: Grant
Title:  NIDCD Clinical Research Center Grant (P50/Clinical Trial Optional)
Award Organization: NICD
Type/Mechanism: Grant
Funding Opportunity Number: PAR-19-137
Award Amount: $1.5M/year 
Pre-proposals Due:  7 Jan, 2019
Full App Due: February 6, 2019; June 6, 2019; October 4, 2019; February 6, 2020; June 8, 2020; October 6, 2020; February 8, 2021; June 6, 2021; October 6, 2021

Description: The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and amelioration of human communication disorders.  For this announcement, Clinical Research is defined as research involving individuals with communication disorders or data/tissues from individuals with a communication disorder. Examples of such research include but are not limited to, studies of the prevention, pathogenesis, pathophysiology, diagnosis, treatment, management or epidemiology of a disease or disorder of hearing, balance, smell, taste, voice, speech, or language.

Applications may propose a clinical trial but are not required (optional).  

Proposed research must meet 4 essential criteria:

1.  Must be clinical as defined above.
2.  Must have a well-defined central unifying theme consisting of three or more research projects with 1 or more supporting cores as appropriate; one core must be an administrative core.
3.  Each project must be unambiguously related to the central unifying theme. Synergistic and substantial interactions among the projects should be evident.
4.  Must provide multidisciplinary approaches to the central theme, defined as having research projects representing different disciplines, approaches and expertise. 

Additional Information:


NIH Exploratory/Developmental Research Grant Program (Clinical Trial Not Allowed/Clinical Trial Required)

PA-19-053: NIH Exploratory/Developmental Research Grant Program (Clinical Trial Not Allowed) 

PA-19-054: NIH Exploratory/Developmental Research Grant Program (Clinical Trial Required) 

Description: The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. This program is intended to encourage new exploratory and developmental research projects. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

These studies should break new ground or extend previous discoveries toward new directions or applications. Applications for Exploratory/Developmental Research Grant awards should include projects distinct from those supported through the traditional R01 activity code. 

Open Date (Earliest Submission Date): January 16, 2019
Application Due Date(s): February 16, 2019
Expiration Date: January 8, 2022

Information: PA-19-053PA-19-054


broad agency announcement (baa) for extramural biomedical research and development

Announcement: Grant
Title:  BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical Research and Development
Award Organization: USSOCOM 
Type/Mechanism: Grant
Funding Opportunity Number: W81XWH-18-S-SOC1
Web Site: DoD : 
Expected Number of Awards: 2
Period of Performance:  2 years
Open App: 1 Aug 2018
Close App: 31 Jul 2023
Description: A primary emphasis of the USSOCOM Biomedical, Human Performance, and Canine Research Program is to identify and develop techniques, knowledge products, and materiel (medical devices, drugs, and biologics) for early intervention in life-threatening injuries, prolonged field care (PFC), human performance optimization, and canine medicine/performance. Special Operations Forces (SOF) medical personnel place a premium on medical equipment that is small, lightweight, ruggedized, modular, multi-use, and designed for operation in extreme environments. The equipment must be easy to use, require minimum maintenance, and have low power consumption. Drugs and biologics should not require refrigeration or other special handling. All materiel and related techniques must be simple and effective, and easily modified for commercialization. 

Research areas of interest include:

• Canine Medicine: 
o Sensory Optimization and Protection: The proposed project must develop research oriented toward innovative methods that enhance or conserve SOF canine olfactory, visual, and/or auditory performance during combat operations.

Max Funding: Most projects are anticipated to have a total cost at or below $700,000 (including indirect costs). Projects that have a total cost higher than $700,000 (including Indirect costs) with outstanding scientific merit that meet a critical need may be accepted; however the total cost of these projects are not to exceed $1,500,000 (including Indirect costs). No budget will be approved by the Government exceeding $1,500,000 (including indirect costs).

Brain initiative

Announcement: RFA-NS-18-030
Award Organization: National Institute of Health (NIH)
Type/Mechanism:  Reissue of RFA-NS-18-009
Activity Code: R01 Research Project Grant
Web Site:
Award Amount: Max funding: $15M to fund 20 awards
PoP: Up to 5 years
Pre-Application Due: Earliest Submission Date: 3 June 2018
Application Due Dates: 6 Novemebr 2018; 3 July 2019; 1 July 2020; 10 November 2020
 Notes: The primary goal of this FOA is to solicit research projects using innovative, methodologically-integrated approaches to understand how circuit activity gives rise to mental experience and behavior.  The activity of neural circuits is the substrate of cognitive processes such as perception, attention, reasoning, intention, decision-making, and emotion. These internal activities are translated into patterns of activation that support simple motor behaviors, as well as more complex behaviors such as navigation and communication. Dysfunction of these large systems of neurons due to disease, injury, or developmental anomaly is the basis of neural and mental disorders. A mission of the NIH BRAIN Initiative is to understand how large scale neural systems contribute to cognitive and neurological function in both health and disease.


Research Interests of the Air Force Office of Scientific Research

Announcement: BAA-AFRL-AFOSR-2016-0007
Award Organization: Air Force Office of Scientific Research
Type/Mechanism: Grant
Activity Code: 
Web Site: DoD:
Award Amount: $200,000 - $400,000 encouraged; $7.5M max
PoP: 5 years
Restrictions: None
Rolling Annual Programs: Open until Superseded
Pre-Application Due: Open until superseded
Full App Due: Open until superseded
Notes: For the sensory systems portion of the portfolio a goal is to pursue new capabilities in acoustic analysis, to enhance the intelligibility and usefulness of acoustic information. The primary approach is to discover, develop, and test principles derived from an advanced understanding of cortical and sub-cortical processes in the auditory brain. Included are efforts to model and control effects of noise interference and reverberation, understand the psychoacoustic basis of informational masking, develop new methods for automatic speech detection, classification, and identification, and enable efficient 3D spatial segregation of multiple overlapping acoustic sources.

AFOSR - Chemistry and Biological Sciences -Human Performance and Biosystems

Announcement: Human Performance and Biosystems
Award Organization: AFRL
Type/Mechanism: Grant
Activity Code: 
Web Site: DoD:
Award Amount: Contact Program Officer Dr. Patrick O. Bradshaw 703-588-8492
PoP: 3-5 years 
Restrictions: See site
Rolling Annual Programs: 
Pre-Application Due:
 Contact Program Officer Dr. Patrick O. Bradshaw 703-588-8492
Full App Due:Contact Program Officer Dr. Patrick O. Bradshaw 703-588-8492
Notes: The primary goal for this program is to gain a better understanding of the biophysical, biochemical, and physiological mechanisms responsible for the behavioral, genetic, cellular, tissue and systems changes resulting from various forms of bio-stimulation. Additionally, a sensory systems focus has been added to this program and the emphasis is on developing the basic scientific foundation to understand and emulate sensory information systems. Emphasis is on (a) acoustic information analysis, especially in relation to human auditory perception, and (b) sensory and sensorimotor systems that enable 3D airborne navigation and control of natural flight, e.g., in insects or bats, especially in relation to capabilities of autonomous biological systems not yet emulated in engineered flight.  For the sensory systems portion of the portfolio a goal is to pursue new capabilities in acoustic analysis, to enhance the intelligibility and usefulness of acoustic information. The primary approach is to discover, develop, and test principles derived from an advanced understanding of cortical and sub-cortical processes in the auditory brain. Included are efforts to model and control effects of noise interference and reverberation, understand the psychoacoustic basis of informational masking, develop new methods for automatic speech detection, classification, and identification, and enable efficient 3D spatial segregation of multiple overlapping acoustic sources. Signal analysis methods based upon purely statistical or other conventional "blind source" approaches are not as likely to receive support as approaches based upon auditory system concepts that emphasize higher-level neural processes not yet fully exploited in engineered algorithms for acoustic information processing. Applicants are encouraged to develop collaborative relationships with scientists in the Air Force Research Laboratory (AFRL).

DOD USAMRMC FY18-FY22 Broad agency announcement for extramural medical research

Announcement: W81XWH18SBAA1
Award Organization: U.S. Army Medical Research and Material Commnad's
Type/Mechanism: Grants Notice
Activity Code: USC, Title 10, Section 2358
Web Site:
Award Amount:  
PoP: 4 years 
Rolling Annual Programs:
Pre-Application Due: Oct 1, 2017
Full Application Due :  September 30, 2022, 11:59 p.m. ET
Notes: Clinical and Rehabilitative Medicine Research Program focus on the innovations required to reset our wounded Service members, both in terms of duty performance and quality of life. Innovations developed from CRMRP-supported research efforts are expected to improve restorative treatments and rehabilitative care to maximize function for return to duty (RTD) or civilian life. 
The CRMRP focuses its efforts on the following research areas: neuromusculoskeletal injury (including limb trauma and amputation), sensory systems impairment (including hearing, balance, tinnitus, and vision), acute and chronic pain, and regenerative medicine.

improving Outcomes for Disorders of Human Communications

Announcement: PA-18-288
Award Organization: National Institute of Health
Type/Mechanism: Grant
Activity Code: R21 Exploratory Development Research Grant
Web Site: 
Award Amount:  The combined budget for direct costs for the two-year project period may not exceed $275,000.  No more than $200,000 may be requested in any single year. 
PoP: 3 years 
Rolling Annual Programs:
Pre-Application Due: Jan. 17, 2018 
Full Application Due :  May 8, 2020
Notes: The purpose of this Funding Opportunity Announcement (FOA) is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. 

Improving Outcomes for Disorders of Human Communication (R01 CLINICAL Trial Optional)

Announcement: PA-18-287
Award Organization: National Institute of Health
Type/Mechanism: Grant
Activity Code: R01 Research Project Grant
Web Site: 
Award Amount:  Application budgets are not limited but need to reflect the actual needs of the proposed project. 
PoP: 5 years 
Pre-Application Due: Jan 6, 2018
Full Application Due :  May 8, 2020
Notes: The purpose of this Funding Opportunity Announcement (FOA) is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. 

Quick Fact


Noise-induced hearing loss, or NIHL, is one of the most common occupational injuries.

About Us

The Hearing Center of Excellence fosters and promotes the prevention, diagnosis, mitigation, treatment, rehabilitation and research of hearing loss and auditory injury. It supports the development, exchange and adoption of best practices, research, measures of effectiveness and clinical care guidelines to reduce the prevalence and cost of hearing loss and tinnitus among Warriors and Veterans. Read more

Hearing Health Challenge For Change

Take the challenge, pledge your commitment, and share your story in the prevention of hearing loss in America today.

The Hearing Center of Excellence is committed to promoting Hearing Loss Programs and Hearing Loss Prevention Initiatives across the DoD. Take the pledge to implement the Comprehensive Hearing Health Program (CHHP) at your local clinic and share with us how it's going for you!

Pledge on Facebook Pledge on Twitter
Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.